Esserman brings urgency for ‘learning healthcare’ to learn faster, better
Breast cancer pioneer tells The BioCentury Show how I-SPY2.2, WISDOM trial and EHRs can tailor better treatment to more women
Laura Esserman wants to raise the bar on turning treatment outcomes into better patient care, and the speed at which healthcare systems can learn from the data they generate. On the latest episode of The BioCentury Show, she carries this thread through a discussion on the next phase of the I-SPY 2 trial, ensuring diversity in clinical trials, and initiatives to expand the adoption and utility of electronic health records.
Esserman, a professor of surgery and radiology at the University of California San Francisco and director of UCSF’s Carol Franc Buck Breast Care Center, is one of the principal architects of the I-SPY 2 breast cancer adaptive trial, which aims to advance precision medicine by using molecular signatures to drive treatment paradigms...